Key Takeaways
- • American Tower (AMT) closed at $164.78 in the most recent session, up 1.55%, outperforming the S&P 500's 0.58% gain, per Zacks-sourced market data.
- • Analyst price targets cluster well above the current price: Morgan Stanley reiterated a Buy rating with a $220 target, while aggregated averages range from roughly $210 to $217, with one tally of 22 Bullish, 0 Bearish and 3 Neutral ratings.
- • AMT has declined 7.73% over the past month, lagging the Finance sector's 4.49% loss and the S&P 500's 0.84% gain.
- • Consensus expects Q3 EPS of $2.84 (up 2.16% year over year) and revenue of $2.77 billion (up 2.06%) when the company reports on October 27, 2026.
- • The Zacks Rank for AMT is #3 (Hold).
Summary
American Tower (AMT) closed its most recent trading session at $164.78, a gain of 1.55% from the prior day's close, according to Zacks-sourced market coverage. The move outpaced the S&P 500, which rose 0.58%, the Dow, up 0.49%, and the Nasdaq, up 0.45%. Despite the single-session advance, the wireless infrastructure REIT has fallen 7.73% over the past month, underperforming both the Finance sector's 4.49% decline and the S&P 500's 0.84% gain. Zacks currently assigns the stock a #3 (Hold) rank.
Sell-side sentiment remains constructive. Morgan Stanley reiterated a Buy rating and a $220 price target, and shares have been little changed following that note. Aggregated analyst data cited by several market-data providers put the average twelve-month price target between roughly $210 and $217, implying upside of about 15% to 30% from recent levels depending on the source and timing of the figures. One aggregator reports 22 Bullish, 0 Bearish and 3 Neutral ratings, while another cites a price target near $237.64. Estimates vary across providers, so the upside figures should be read as approximate.
Investors will focus on the company's upcoming quarterly report, scheduled for October 27, 2026. The Zacks Consensus Estimate calls for EPS of $2.84, up 2.16% from the prior-year quarter, and revenue of $2.77 billion, up 2.06%. For the full year, consensus projects earnings of $11.11 per share, up 3.25%, and revenue of $11.04 billion, up 3.68%. Zacks notes that upward revisions to estimates tend to track near-term stock performance, and its #3 rank reflects a neutral reading of recent estimate changes.
Sell-side sentiment remains constructive. Morgan Stanley reiterated a Buy rating and a $220 price target, and shares have been little changed following that note. Aggregated analyst data cited by several market-data providers put the average twelve-month price target between roughly $210 and $217, implying upside of about 15% to 30% from recent levels depending on the source and timing of the figures. One aggregator reports 22 Bullish, 0 Bearish and 3 Neutral ratings, while another cites a price target near $237.64. Estimates vary across providers, so the upside figures should be read as approximate.
Investors will focus on the company's upcoming quarterly report, scheduled for October 27, 2026. The Zacks Consensus Estimate calls for EPS of $2.84, up 2.16% from the prior-year quarter, and revenue of $2.77 billion, up 2.06%. For the full year, consensus projects earnings of $11.11 per share, up 3.25%, and revenue of $11.04 billion, up 3.68%. Zacks notes that upward revisions to estimates tend to track near-term stock performance, and its #3 rank reflects a neutral reading of recent estimate changes.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.